Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: Murray_Mac who wrote (1396)	4/25/2000 12:50:00 PM
From: Murray_Mac	Respond to of 3392

CYBR is now under $20 --- please ponder the following: 1. CYBR is the leader in its field of Telemedicine 2. Has a product that saves 35% of cost in the 2nd largest market in the USA (health 2nd only to the defense industry!) 3. Uses a booming and near ubiquitous internet medium 4. Has virtually no credible competition 5. Has booked nearly a billion dollars in orders in the last six months 6. Is fully protected by patents 7. Is experiencing explosive worldwide demand far beyond any reasonable expectation of company management 8. Is on the verge of FDA approval 9. Has a product that is sought after by governments, hospitals, health insurance companies, doctors, and a variety of other health related sectors around the world. 10. Selects 1st USA Manufacturer (Colin Medical Instruments, ISO 9001 certified) and CYBR will shortly announce others to handle the large USA pent-up demand for the Electronic HouseCall System MY Conclusion --- this equity is a very strong buy! Justifying my contention that CYBR share price is highly undervalued in my DD Must See link -- ragingbull.com Based on the fact that CYBR has on the books, right now, firm commitments for 100,000+ EHC unites that will be deployed over a span of 4 years. Its quite apparent that few have recognized the financial impact 100K units will make. Number of shares (fully diluted) = 68 million Projected Net Revenue at full deployment = 240 million (100K EHC's @ [$200 monthly reoccurring times 12]) Projected Earnings per share (EPS) = $3.53 (Net Revenue divided by Number of shares) Price to Earnings per share (PE/s) = $71.00 (EPS times a conservative multiple of 20) April 24, 2000 CYBR closing-price = $12.00 Now ponder the fact that my EPS calculations above do not take into account any (a) net revenue from the sale of EHC?s [projected at 225 million for 100K EHC] (b) revenues that will be generated licensing Cyber-Care EHC Patent (c) any revenues that will be earned from joint venture agreements. If you?re wondering why I have not included this other revenue stream ? because CYBR have not divulged information for (b) and (c) ----- and I left out (a) to be very conservative. Do you want to consider the potential PE/S -- when 1.1 million EHC unites will be sold/deployed and the resulting NETWORK reoccurring NET revenues earned? (My guess is that 1.1 million EHC's will become a fact by late summer of 2003) Projected Net Revenue = $2.64 billion Projected Earnings per share (EPS) = $38.82 Price to Earnings per share (PE/s) = $776 April 24, 2000 CYBR closing-price = $12.00 CYBR info -- the following links will be helpful Cyber-Care History ---------------- ragingbull.com Where is CyberCare headed?-- ragingbull.com BSP?s EBITDA model ------------ ragingbull.com Contract progress review -------- ragingbull.com Straight talk on share dilution --- ragingbull.com The billion dollar maker ----------- ragingbull.com A courtesy post to weak hands - ragingbull.com Short Attack on CYBR ------------- ragingbull.com Cyber-Care Technologies WEB site cyber-care.net Cyber-Care WEB site cyber-care.net ..DM.. (Voluntary Disclosure: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy)